REV 5901 hydrochloride is a competitive and orally active antagonist of leukotriene receptor , with a K i of 0.7 μM. REV 5901 hydrochloride is also a 5-lipoxygenase inhibitor. REV 5901 hydrochloride can be used for the research of asthma in which leukotriene release be involved.